About us

ABOUT

StatuManu ICP Aps is a Danish medical device start-up. StatuManu ICP is developing a software as a service medical device, based on deep learning methods, for non-invasive measurement and monitoring of intracranial pressure.

WHY?

Since the 1920s, scientists have worked on developing methods for measuring the pressure in the brain without having to drill a hole in the cranium. Here, the identification of the causes for increased pressure is important for diagnosing the condition and treating the pressure. StatuManu ICP will provide a service not yet present in the market of ICP monitoring. As a non-invasive solution, the ICP Tracker eliminates critical risks associated with current methods, beneficial for both patients and society. 

BACKGROUND

StatuManu was founded in 2015 and now consists of six employees. We continue to work with the development of the software solution until we are able to help solve the clinical need for non-invasive measurement of ICP. As a company, StatuManu ICP’s mission is to save brain to save lives by enabling fast, reliable and non-invasive assessment of ICP, and being positioned as the standard tool for ICP monitoring. 

THE GOAL

The valuable contribution of ICP Tracker is evident as symptoms of elevated ICP often mimic those of other less dangerous illnesses. The goal is that non-invasive methods to detect possible changes in ICP will be used in all instances of suspected elevated ICP.

SOLVING A WELL-DEFINED CLINICAL NEED

StatuManu ICP Aps is a Danish medical device start-up. StatuManu ICP is developing a software as a service medical device, based on deep learning methods, for non-invasive measurement and monitoring of intracranial pressure.

Since the 1920s, scientists have worked on developing methods for measuring the pressure in the brain without having to drill a hole in the cranium. Here, the identification of the causes for increased pressure is important for diagnosing the condition and treating the pressure. StatuManu ICP will provide a service not yet present in the market of ICP monitoring. As a non-invasive solution, the ICP Tracker eliminates critical risks associated with current methods, beneficial for both patients and society.

Meet the team

PATI REITER
CEO

MATHILDE BIRN
Director, Business Development

FREDERIK DRACHMANN
Lead Software Developer 

TORD KVIFTE
Software Developer

MARIA NIELSEN
QA Assistant

LAURYNAS ZUBAVICIUS
QA Assistant

DARIUS CHIRA
Software Developer

ILIAN HARALAMPIEV
Software Developer

Scroll to Top